These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23563029)

  • 1. Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.
    Bienert A; Bartkowska-Sniatkowska A; Wiczling P; Rosada-Kurasińska J; Grześkowiak M; Zaba C; Teżyk A; Sokołowska A; Kaliszan R; Grześkowiak E
    Pharmacol Rep; 2013; 65(1):107-21. PubMed ID: 23563029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis.
    Kos MK; Miksić M; Jovanović M; Roškar R; Grosek Š; Grabnar I
    Eur J Pharm Sci; 2020 Jan; 141():105095. PubMed ID: 31626965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.
    Zuppa AF; Conrado DJ; Zane NR; Curley MAQ; Bradfield J; Hakonarson H; Gastonguay MS; Moorthy G; Prodell J; Gastonguay MR
    Crit Care Med; 2019 Apr; 47(4):e301-e309. PubMed ID: 30672747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
    Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
    Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients.
    Bienert A; Kusza K; Wawrzyniak K; Grześkowiak E; Kokot ZJ; Matysiak J; Grabowski T; Wolc A; Wiczling P; Regulski M
    J Pharmacokinet Pharmacodyn; 2010 Jun; 37(3):289-304. PubMed ID: 20544262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of interrupted versus continuous sedative infusions in ventilated children.
    Gupta K; Gupta VK; Jayashree M; Singhi S
    Pediatr Crit Care Med; 2012 Mar; 13(2):131-5. PubMed ID: 21283046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age is of influence on midazolam requirements in a paediatric intensive care unit.
    de Gast-Bakker DA; van der Werff SD; Sibarani-Ponsen R; Swart EL; Plötz FB
    Acta Paediatr; 2007 Mar; 96(3):414-7. PubMed ID: 17407468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
    Franken LG; Masman AD; de Winter BCM; Baar FPM; Tibboel D; van Gelder T; Koch BCP; Mathot RAA
    Br J Clin Pharmacol; 2017 Aug; 83(8):1701-1712. PubMed ID: 28177137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.
    Zomorodi K; Donner A; Somma J; Barr J; Sladen R; Ramsay J; Geller E; Shafer SL
    Anesthesiology; 1998 Dec; 89(6):1418-29. PubMed ID: 9856717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proof of Concept: First Pediatric [
    van Groen BD; van Duijn E; de Vries A; Mooij MG; Tibboel D; Vaes WHJ; de Wildt SN
    Clin Pharmacol Ther; 2020 Nov; 108(5):1003-1009. PubMed ID: 32386327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
    Tse AHW; Ling L; Lee A; Joynt GM
    Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children.
    Tobias JD
    Crit Care Med; 1999 Oct; 27(10):2262-5. PubMed ID: 10548218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Effects of Continuous Dexmedetomidine Infusion Without a Loading Dose in the Pediatric Intensive Care Unit.
    Cummings BM; Cowl AS; Yager PH; El Saleeby CM; Shank ES; Noviski N
    J Intensive Care Med; 2015 Dec; 30(8):512-7. PubMed ID: 24923492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis of circadian rhythms in hepatic CYP3A activity using midazolam.
    Tomalik-Scharte D; Suleiman AA; Frechen S; Kraus D; Kerkweg U; Rokitta D; Di Gion P; Queckenberg C; Fuhr U
    J Clin Pharmacol; 2014 Oct; 54(10):1162-9. PubMed ID: 24782075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units.
    Fragen RJ
    Clin Ther; 1997; 19(3):405-19; discussion 367-8. PubMed ID: 9220206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.